Transitional Year·Plano, TX

HCA Medical City Healthcare GME (Plano)

Signal lift29%49%+20 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
251–272
p10 – p90
Sample N
629
applicants this cycle
This cycle
no tracked aways yet
Match rate
1.9%
12 of 117 applicants
01Cohort funnelthis cycle
N = 629
Applied
629
100.0%
Invited
117
18.6%
Class size
12
1.9%
No visa sponsorshipPreliminary
Your fitHCA Medical City Healthcare GME (Plano) Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at HCA Medical City Healthcare GME (Plano) Program

Create free account
Contact
MS
Program Director
Muhammad Talal Siddique, MD, MD
Email director
SP
Program Coordinator
Shaniquwa Patrick
Email coordinator
Training sites3 hospitals · Plano
  • 1
    HCA Medical City Healthcare GME
    Dallas, TX
    Primary
  • 2
    Medical Center of Plano
    Plano, TX
    Participant
  • 3
    Passion Health Primary Care-Plano
    Plano, TX
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK251272
180205230255280

Level 2 CE data not available

Interview rates
US MD
30%
US DO
9%
US IMG
0%
Non-US IMG
0%
Applicant origin
In-state
50%
Out-of-state
1%
Interview prepTransitional Year
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add HCA Medical City Healthcare GME (Plano) to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Transitional Year.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.